FDA Adverse Event Malfunction Summary report: N

FT3 III - FREE TRIIODOTHYRONINE

MDR report key: 6184468 · Received December 18, 2016

Report

Report Number
1823260-2016-01977
Event Type
Malfunction
Date Received
December 18, 2016
Date of Event
November 28, 2016
Report Date
December 18, 2016
Manufacturer
ROCHE DIAGNOSTICS
Product Code
CDP
PMA / PMN Number
K963127
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B)(4). THIS EVENT OCCURRED IN (B)(6).

Description of Event or Problem · 1

THE CUSTOMER RECEIVED QUESTIONABLE THYROID RESULTS FOR ONE PATIENT SAMPLE USING A COBAS 6000 E 601 MODULE. THE SERIAL NUMBER WAS REQUESTED BUT WAS NOT PROVIDED. THE CUSTOMER EVALUATED THE SAMPLE USING GEL FILTRATION AND FOUND DISCREPANT RESULTS FOR THE ELECSYS FT4 II ASSAY. THE SAMPLE WAS SUBMITTED FOR INVESTIGATION AND WAS TESTED ON A COBAS 6000 E 601 MODULE AND A COBAS E 411 IMMUNOASSAY ANALYZER. DISCREPANT RESULTS WERE FOUND FOR THE ELECSYS FT3 III. REFER TO THE ATTACHMENT TO THE MEDWATCH FOR ALL PATIENT DATA. REFER TO THE MEDWATCH WITH A1 PATIENT IDENTIFIER (B)(6) FOR THE FT4 ASSAY. THE ERRONEOUS RESULTS WERE NOT REPORTED OUTSIDE THE LABORATORY. THE PATIENT WAS NOT ADVERSELY AFFECTED. IT WAS SUSPECTED THE ISSUE WAS DUE TO STREPTAVIDIN INTERFERENCE. A SPECIFIC ROOT CAUSE COULD NOT BE DETERMINED AS NO SAMPLE MATERIAL REMAINED FOR FURTHER INVESTIGATION. FROM INVESTIGATION OF THE INFORMATION PROVIDED, A GENERAL REAGENT ISSUE WAS NOT DETECTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
834995 FT3 III - FREE TRIIODOTHYRONINE RADIOIMMUNOASSAY, TOTAL TRIIODOTHYRONINE CDP ROCHE DIAGNOSTICS NA ASKU

Patients

Seq Age Sex Outcome Treatment
1 32 YR